Industry: Medical Devices & Consumables
Published Date: 2026-05-30
Pages: 143 Pages
Report ld: 5564356
Request Sample
Customized Report
Automatic Erythrocyte Sedimentation Rate Analyzer Market Size(US$)

CAGR 2026-2032
4.9%
Market Size,2032
USD 415
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Automatic Erythrocyte Sedimentation Rate Analyzer market size was US$ 296 million in 2025 and is forecast to reach a readjusted size of US$ 415 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
The automated erythrocyte sedimentation rate (ESR) analyzer is an in vitro diagnostic device designed for the automated measurement of the erythrocyte sedimentation rate in blood samples. It primarily monitors the sedimentation changes of erythrocytes over a specific period using optical, electromagnetic induction, or image recognition technologies. These analyzers are utilized in various clinical settings, including the diagnosis of inflammation, infections, and rheumatic-immunological diseases; the auxiliary screening for tumors; and the monitoring of chronic conditions. In 2025, global sales are projected to reach approximately 1.048 million units, with an average unit price of approximately $850. The industry's capacity utilization rate is estimated at around 72%. Upstream enterprises in the supply chain primarily consist of manufacturers of precision injection-molded parts, optoelectronic sensors, stepper motors, control boards, embedded software, test tube racks, blood collection consumables, and various in vitro diagnostic components. Downstream entities—the end-users—mainly comprise hospital clinical laboratories, third-party medical testing laboratories, health examination centers, primary healthcare institutions, private clinics, and scientific research and testing organizations. The industry's gross profit margin stands at approximately 42%. Regarding the product cost structure, electronic components account for 28%, mechanical structural parts for 20%, optical detection modules for 16%, software and control systems for 10%, assembly labor for 9%, quality control testing for 7%, packaging and logistics for 5%, and other miscellaneous expenses for 5%. The demand landscape encompasses routine hospital blood testing requirements, auxiliary testing for inflammatory markers, screening for rheumatic-immunological diseases, rapid testing needs in primary healthcare settings, high-volume testing requirements in health examination centers, and the broader demand for laboratory automation upgrades. The downstream client base includes general hospitals, specialized hospitals, regional testing centers, third-party medical testing agencies, chain-based health examination centers, primary healthcare service centers, and medical research institutions. In terms of market opportunities, growth is primarily driven by policy initiatives such as hierarchical diagnosis and treatment systems, the enhancement of testing capabilities in primary healthcare institutions, the automation of hospital laboratories, and the localization of in vitro diagnostic equipment to replace imports. Technological innovation serves as another key driver, manifested through advancements in miniaturization with automated sample loading, rapid detection algorithms, low-sample-volume testing capabilities, barcode recognition, data networking, and integration with Laboratory Information Systems (LIS). Furthermore, evolving user demands reflect a growing emphasis among healthcare institutions on testing efficiency, sample safety, operational simplicity, result consistency, and reduced maintenance costs; this trend is propelling the development of automated ESR analyzers from single-function testing devices toward solutions characterized by high throughput, intelligence, low maintenance requirements, and suitability for primary healthcare environments.
Automated erythrocyte sedimentation rate (ESR) analyzers represent a mature category of routine *in vitro* diagnostic (IVD) equipment that nonetheless continues to exhibit steady incremental growth. Core growth drivers do not rely solely on new procurement by individual large-scale hospitals; rather, they stem from the replacement of existing manual testing methods, the standardization of infrastructure in primary healthcare institutions, the automation of clinical laboratory departments, and the continuous drive by third-party testing centers to enhance the efficiency of high-volume sample processing. Around 2025, markets in Europe, the U.S., and Japan—characterized by high installed bases—will see new demand driven primarily by equipment replacement, upgrades, and the adoption of newer high-throughput models. Conversely, markets in China, India, Southeast Asia, Latin America, and the Middle East remain in a phase of increasing automation penetration; here, low-to-medium-throughput products and cost-effective domestic equipment are more likely to capture growth opportunities. Although the unit price of these analyzers is relatively modest, customers place stringent demands on stability, reproducibility, after-sales service, and consumables compatibility. Consequently, the focus of market competition is gradually shifting away from mere hardware pricing toward factors such as testing speed, sample capacity, failure rates, network connectivity capabilities, and total lifecycle costs. From 2026 to 2032, industry sales volume is projected to maintain moderate growth, with an estimated compound annual growth rate (CAGR) of approximately 5% to 7%; within this segment, compact benchtop units are best suited for primary care facilities and clinics, while high-throughput systems are designed for large-scale hospitals and central laboratories. Future business opportunities for enterprises will primarily converge on three strategic directions: first, capturing the primary healthcare market through the deployment of cost-effective automation modules; second, enhancing customer stickiness within hospitals by integrating analyzers with Laboratory Information Systems (LIS), hematology analyzers, and automated laboratory workflows; and third, entering emerging markets through the acquisition of international certifications and the establishment of localized distribution channels. Overall, while automated ESR analyzers are unlikely to experience explosive, rapid growth, their stable testing parameters, broad range of application scenarios, and predictable equipment replacement cycles ensure a steady stream of unit shipments and associated consumables sales. As such, this product category represents an ideal long-term strategic focus for enterprises possessing established IVD distribution channels, robust quality management systems, and effective cost-control capabilities.
The global Automatic Erythrocyte Sedimentation Rate Analyzer market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Automatic Erythrocyte Sedimentation Rate Analyzer sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Automatic Erythrocyte Sedimentation Rate Analyzer manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Automatic Erythrocyte Sedimentation Rate Analyzer product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Automatic Erythrocyte Sedimentation Rate Analyzer value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Automatic Erythrocyte Sedimentation Rate Analyzer Product Scope
1.2 Automatic Erythrocyte Sedimentation Rate Analyzer by Type
1.2.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Type (2021, 2025 & 2032)
1.2.2 Big Sample Numbers
1.2.3 Small Sample Numbers
1.3 Automatic Erythrocyte Sedimentation Rate Analyzer by Application
1.3.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Medical Use
1.3.3 Scientific Research
1.4 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Estimates and Forecasts (2021-2032)
1.4.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Historical Market Scenario by Region (2021-2026)
2.2.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales Market Share by Region (2021-2026)
2.2.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue Market Share by Region (2021-2026)
2.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Automatic Erythrocyte Sedimentation Rate Analyzer Market Size and Prospects (2021-2032)
2.4.2 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Market Size and Prospects (2021-2032)
2.4.3 China Automatic Erythrocyte Sedimentation Rate Analyzer Market Size and Prospects (2021-2032)
2.4.4 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Historical Market Review by Type (2021-2026)
3.1.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Type (2021-2026)
3.1.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Type (2021-2026)
3.1.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Average Price by Type (2021-2026)
3.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales Forecast by Type (2027-2032)
3.2.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue Forecast by Type (2027-2032)
3.2.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Automatic Erythrocyte Sedimentation Rate Analyzer
4 Global Market Size by Application
4.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Historical Market Review by Application (2021-2026)
4.1.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Application (2021-2026)
4.1.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Application (2021-2026)
4.1.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Average Price by Application (2021-2026)
4.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales Forecast by Application (2027-2032)
4.2.2 Global Automatic Erythrocyte Sedimentation Rate Analyzer Revenue Forecast by Application (2027-2032)
4.2.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Automatic Erythrocyte Sedimentation Rate Analyzer Applications
5 Competition Landscape by Players
5.1 Global Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Player (2021-2026)
5.2 Global Top Automatic Erythrocyte Sedimentation Rate Analyzer Players by Revenue (2021-2026)
5.3 Global Automatic Erythrocyte Sedimentation Rate Analyzer Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Automatic Erythrocyte Sedimentation Rate Analyzer revenue as of 2025
5.4 Global Automatic Erythrocyte Sedimentation Rate Analyzer Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Automatic Erythrocyte Sedimentation Rate Analyzer, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Automatic Erythrocyte Sedimentation Rate Analyzer, Product Type & Application
5.7 Global Key Manufacturers of Automatic Erythrocyte Sedimentation Rate Analyzer, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company
6.1.1.1 North America Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company (2021-2026)
6.1.1.2 North America Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Company (2021-2026)
6.1.2 North America Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Type (2021-2026)
6.1.3 North America Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Application (2021-2026)
6.1.4 North America Automatic Erythrocyte Sedimentation Rate Analyzer Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company
6.2.1.1 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company (2021-2026)
6.2.1.2 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Company (2021-2026)
6.2.2 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Type (2021-2026)
6.2.3 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Application (2021-2026)
6.2.4 Europe Automatic Erythrocyte Sedimentation Rate Analyzer Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company
6.3.1.1 China Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company (2021-2026)
6.3.1.2 China Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Company (2021-2026)
6.3.2 China Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Type (2021-2026)
6.3.3 China Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Application (2021-2026)
6.3.4 China Automatic Erythrocyte Sedimentation Rate Analyzer Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company
6.4.1.1 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Sales by Company (2021-2026)
6.4.1.2 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Revenue by Company (2021-2026)
6.4.2 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Type (2021-2026)
6.4.3 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Sales Breakdown by Application (2021-2026)
6.4.4 Japan Automatic Erythrocyte Sedimentation Rate Analyzer Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Alifax (IT)
7.1.1 Alifax (IT) Company Information
7.1.2 Alifax (IT) Business Overview
7.1.3 Alifax (IT) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Alifax (IT) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.1.5 Alifax (IT) Recent Development
7.2 Streck (US)
7.2.1 Streck (US) Company Information
7.2.2 Streck (US) Business Overview
7.2.3 Streck (US) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Streck (US) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.2.5 Streck (US) Recent Development
7.3 ALCOR Scientific (US)
7.3.1 ALCOR Scientific (US) Company Information
7.3.2 ALCOR Scientific (US) Business Overview
7.3.3 ALCOR Scientific (US) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.3.4 ALCOR Scientific (US) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.3.5 ALCOR Scientific (US) Recent Development
7.4 RR Mechatronics (NL)
7.4.1 RR Mechatronics (NL) Company Information
7.4.2 RR Mechatronics (NL) Business Overview
7.4.3 RR Mechatronics (NL) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.4.4 RR Mechatronics (NL) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.4.5 RR Mechatronics (NL) Recent Development
7.5 DIESSE Diagnostica (IT)
7.5.1 DIESSE Diagnostica (IT) Company Information
7.5.2 DIESSE Diagnostica (IT) Business Overview
7.5.3 DIESSE Diagnostica (IT) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.5.4 DIESSE Diagnostica (IT) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.5.5 DIESSE Diagnostica (IT) Recent Development
7.6 Mindray Medical (CN)
7.6.1 Mindray Medical (CN) Company Information
7.6.2 Mindray Medical (CN) Business Overview
7.6.3 Mindray Medical (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Mindray Medical (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.6.5 Mindray Medical (CN) Recent Development
7.7 JOKOH (JP)
7.7.1 JOKOH (JP) Company Information
7.7.2 JOKOH (JP) Business Overview
7.7.3 JOKOH (JP) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.7.4 JOKOH (JP) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.7.5 JOKOH (JP) Recent Development
7.8 Sarstedt (DE)
7.8.1 Sarstedt (DE) Company Information
7.8.2 Sarstedt (DE) Business Overview
7.8.3 Sarstedt (DE) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Sarstedt (DE) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.8.5 Sarstedt (DE) Recent Development
7.9 ELITechGroup (FR)
7.9.1 ELITechGroup (FR) Company Information
7.9.2 ELITechGroup (FR) Business Overview
7.9.3 ELITechGroup (FR) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.9.4 ELITechGroup (FR) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.9.5 ELITechGroup (FR) Recent Development
7.10 Beijing Succeeder (CN)
7.10.1 Beijing Succeeder (CN) Company Information
7.10.2 Beijing Succeeder (CN) Business Overview
7.10.3 Beijing Succeeder (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Beijing Succeeder (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.10.5 Beijing Succeeder (CN) Recent Development
7.11 SFRI (FR)
7.11.1 SFRI (FR) Company Information
7.11.2 SFRI (FR) Business Overview
7.11.3 SFRI (FR) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.11.4 SFRI (FR) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.11.5 SFRI (FR) Recent Development
7.12 HemaTechnologies (US)
7.12.1 HemaTechnologies (US) Company Information
7.12.2 HemaTechnologies (US) Business Overview
7.12.3 HemaTechnologies (US) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.12.4 HemaTechnologies (US) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.12.5 HemaTechnologies (US) Recent Development
7.13 Chongqing Nanfang Numerical Control Equipment (CN)
7.13.1 Chongqing Nanfang Numerical Control Equipment (CN) Company Information
7.13.2 Chongqing Nanfang Numerical Control Equipment (CN) Business Overview
7.13.3 Chongqing Nanfang Numerical Control Equipment (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Chongqing Nanfang Numerical Control Equipment (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.13.5 Chongqing Nanfang Numerical Control Equipment (CN) Recent Development
7.14 Caretium Medical Instruments (CN)
7.14.1 Caretium Medical Instruments (CN) Company Information
7.14.2 Caretium Medical Instruments (CN) Business Overview
7.14.3 Caretium Medical Instruments (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Caretium Medical Instruments (CN) Automatic Erythrocyte Sedimentation Rate Analyzer Products Offered
7.14.5 Caretium Medical Instruments (CN) Recent Development
8 Automatic Erythrocyte Sedimentation Rate Analyzer Manufacturing Cost Analysis
8.1 Automatic Erythrocyte Sedimentation Rate Analyzer Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Automatic Erythrocyte Sedimentation Rate Analyzer
8.4 Automatic Erythrocyte Sedimentation Rate Analyzer Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Automatic Erythrocyte Sedimentation Rate Analyzer Distributors List
9.3 Automatic Erythrocyte Sedimentation Rate Analyzer Customers
10 Automatic Erythrocyte Sedimentation Rate Analyzer Market Dynamics
10.1 Automatic Erythrocyte Sedimentation Rate Analyzer Industry Trends
10.2 Automatic Erythrocyte Sedimentation Rate Analyzer Market Drivers
10.3 Automatic Erythrocyte Sedimentation Rate Analyzer Market Challenges
10.4 Automatic Erythrocyte Sedimentation Rate Analyzer Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Automatic Erythrocyte Sedimentation Rate Analyzer market is projected to grow from US$ 296 million in 2025 to US$ 415 million by 2032, at a CAGR of 4.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-30
Pages: 152
USD 4900.00
(Single User License)
The global Automatic Erythrocyte Sedimentation Rate Analyzer market was valued at US$ 296 million in 2025 and is anticipated to reach US$ 415 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 122
USD 2900.00
(Single User License)
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 296 million in 2025 and is projected to reach US$ 415 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 142
USD 3950.00
(Single User License)
The global Automatic Erythrocyte Sedimentation Rate Analyzer market size was US$ 74.3 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 99
USD 4250.00
(Single User License)
The global Automatic Erythrocyte Sedimentation Rate Analyzer market is projected to grow from US$ 74.3 million in 2024 to US$ 103 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 167
USD 4900.00
(Single User License)
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 74.3 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-08-05
Pages: 124
USD 3950.00
(Single User License)
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was valued at US$ 74.3 million in the year 2024 and is projected to reach a revised size of US$ 103 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-08-05
Pages: 89
USD 2900.00
(Single User License)
In 2024, the global market size of Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 66.7 million and is forecast to reach approximately US$ 90.4 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 200
USD 5900.00
(Single User License)
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 66.7 million in 2024 and is forecast to a readjusted size of US$ 90.4 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 165
USD 3950.00
(Single User License)
This report studies Automatic Erythrocyte Sedimentation Rate Analyzer/ESR (Sed Rate) Analyzers market. The erythrocyte sedimentation rate, also known as the ESR or sed rate, is a clinical lab test that measures the rate at which red blood cells in whole blood descend into a standardized tube, reported as mm per hour. It is often used to screen patients with fevers of undetermined origin, arthritides, muscle pains, and other vague symptoms. ESR testing is specifically indicated for certain conditions: to monitor rheumatoid arthritis, tuberculosis, and systemic lupus erythematosis; and to diagnose and monitor giant cell arteritis and polymyalgia rheumatica. An elevated ESR may also be associated with many other conditions, including other autoimmune disease, anemia, infection, and malignancy.
Published Date: 2024-10-11
Pages: 170
USD 4350.00
(Single User License)
The global Automatic Erythrocyte Sedimentation Rate Analyzer market is projected to grow from US$ 296 million in 2025 to US$ 415 million by 2032, at a CAGR of 4.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-30
Pages: 152
The global Automatic Erythrocyte Sedimentation Rate Analyzer market was valued at US$ 296 million in 2025 and is anticipated to reach US$ 415 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-05-30
Pages: 122
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 296 million in 2025 and is projected to reach US$ 415 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-05-30
Pages: 142
The global Automatic Erythrocyte Sedimentation Rate Analyzer market size was US$ 74.3 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 99
The global Automatic Erythrocyte Sedimentation Rate Analyzer market is projected to grow from US$ 74.3 million in 2024 to US$ 103 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 167
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 74.3 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-08-05
Pages: 124
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was valued at US$ 74.3 million in the year 2024 and is projected to reach a revised size of US$ 103 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-08-05
Pages: 89
In 2024, the global market size of Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 66.7 million and is forecast to reach approximately US$ 90.4 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 200
The global market for Automatic Erythrocyte Sedimentation Rate Analyzer was estimated to be worth US$ 66.7 million in 2024 and is forecast to a readjusted size of US$ 90.4 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 165
This report studies Automatic Erythrocyte Sedimentation Rate Analyzer/ESR (Sed Rate) Analyzers market. The erythrocyte sedimentation rate, also known as the ESR or sed rate, is a clinical lab test that measures the rate at which red blood cells in whole blood descend into a standardized tube, reported as mm per hour. It is often used to screen patients with fevers of undetermined origin, arthritides, muscle pains, and other vague symptoms. ESR testing is specifically indicated for certain conditions: to monitor rheumatoid arthritis, tuberculosis, and systemic lupus erythematosis; and to diagnose and monitor giant cell arteritis and polymyalgia rheumatica. An elevated ESR may also be associated with many other conditions, including other autoimmune disease, anemia, infection, and malignancy.
Published: 2024-10-11
Pages: 170
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now